Inactive Instrument

LARR HEALPAR

LSPR

US51724W1071

Larkspur Health Acquisition Corp. has Changed its Name to ZyVersa Therapeutics, Inc

December 09, 2022 at 09:01 pm

Larkspur Health Acquisition Corp. changed its name to ZyVersa Therapeutics, Inc.

Latest news about LARR HEALPAR

Larkspur Acquisition Completes Merger With ZyVersa Therapeutics	13/12/22	MT
Larkspur Health Acquisition Corp.(NasdaqGM:LSPR) dropped from NASDAQ Composite Index	12/12/22	CI
Larkspur Health Acquisition Corp. announced that it has received $8.635 million in funding	11/12/22	CI
ZyVersa Therapeutics, Inc. completed the acquisition of Larkspur Health Acquisition Corp. from Larkspur Health LLC, A.G.P. / Alliance Global Partners Corp. and others in a reverse merger transaction.	11/12/22	CI
Larkspur Health Acquisition Corp. has Changed its Name to ZyVersa Therapeutics, Inc	09/12/22	CI
Larkspur Health Acquisition Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	14/11/22	CI
Larkspur Health Acquisition Refiles Registration Statement for Business Combination Agreement With ZyVersa Therapeutics	27/09/22	MT
Larkspur Health Acquisition Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	15/08/22	CI
ZyVersa Therapeutics to Merge with Larkspur Health Acquisition, Obtain Nasdaq Listing	21/07/22	MT
Larkspur Health Acquisition Corp. announced that it expects to receive $7 million in funding	19/07/22	CI
ZyVersa Therapeutics, Inc. executed a confidential non -binding term sheet to acquire Larkspur Health Acquisition Corp. in a reverse merger transaction for approximately $190 million.	19/07/22	CI
Certain Class B Common Stock of Larkspur Health Acquisition Corp. are subject to a Lock-Up Agreement Ending on 20-JUN-2022.	19/06/22	CI
Larkspur Health Acquisition Corp. Reports Earnings Results for the First Quarter Ended March 31, 2022	13/05/22	CI
Larkspur Health Acquisition Corp. Reports Earnings Results for the Nine Months Ended December 31, 2021	15/04/22	CI
Larkspur Health Acquisition Corp. Auditor Raises 'Going Concern' Doubt	14/04/22	CI
Larkspur Health Acquisition Consents to Replace Audit Committee Chair Raj Mehra with Gregory Skalicky	11/02/22	CI
Larkspur Health Acquisition Corp.(NasdaqGM:LSPR) added to NASDAQ Composite Index	11/02/22	CI
Larkspur Health Acquisition Corp. has completed an IPO in the amount of $75 million.	20/12/21	CI
Larkspur Health Acquisition Corp. announced that it expects to receive $2.426 million in funding from Larkspur Health Llc	12/05/21	CI
Larkspur Health Acquisition Corp. has filed an IPO in the amount of $75 million.	12/05/21	CI

Larkspur Health Acquisition Corp is a blank check company. The Company is formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The Company intends to focus its search on companies in the biotechnology sector in the United States. The Company is not engaged in any business operations and has not generated any revenue.

Sector

More about the company

LARR HEALPAR

Equities

LSPR

US51724W1071

Larkspur Health Acquisition Corp. has Changed its Name to ZyVersa Therapeutics, Inc

Latest news about LARR HEALPAR

Chart LARR HEALPAR

Company Profile